Information  X 
Enter a valid email address

Benchmark Hlgs PLC (BMK)


Friday 16 August, 2019

Benchmark Hlgs PLC

Details of Investor Call

RNS Number : 3918J
Benchmark Holdings PLC
16 August 2019


16 August 2019


Benchmark Holdings plc


("Benchmark" or the "Company")


Details of Investor Call


Benchmark, the aquaculture health, advanced nutrition and genetics business, announces that following its recent Trading Update on 12 August, management will be hosting an investor call at 12:00 noon GMT on Monday, 19 August 2019, where it will provide further guidance on that update and seek to address questions raised by investors. The call will be accompanied by a short presentation which will be posted on the Company's website at following the call.

To register your interest for the call, please contact [email protected] or call on +44 (0)20 3128 8742. A replay of the call will be available for three days. To request a link of the recording of the call please contact MHP on the same details above.




For further information, please contact:

Benchmark Holdings plc

Tel:  020 3915 1236

Malcolm Pye, CEO

Mark Plampin, CFO

Ivonne Cantu, Investor Relations

Numis (Broker and NOMAD)

Tel:  020 7260 1000

James Black, Freddie Barnfield, Freddie Naylor-Leyland


MHP Communications

Tel:  020 3128 8742

Katie Hunt / Reg Hoare / Alistair de Kare-Silver                                            [email protected]



About Benchmark 
Benchmark's mission is to enable food producers to improve their sustainability and profitability.

We bring together biology and technology, to develop innovative products which improve yield, quality and animal health and welfare for our customers. We do this by improving the genetic make-up, health and nutrition of their stock - from broodstock and hatchery through to nursery and grow out.

Benchmark has a broad portfolio of products and solutions, including salmon eggs, live feed (artemia), sea lice treatments, training and data management tools. Find out more at


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit

a d v e r t i s e m e n t